Skip to main content
Erschienen in: Abdominal Radiology 7/2020

02.12.2019 | Special Section: Male pelvis

Post-treatment prostate MRI

verfasst von: Theodora A. Potretzke, Adam T. Froemming, Rajan T. Gupta

Erschienen in: Abdominal Radiology | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Accurate early detection of recurrent prostate cancer after surgical or nonsurgical treatment is increasingly relevant in the era of evolving options for salvage therapy. The importance of differentiating between local tumor recurrence, distant metastatic disease, and a combination of both in a patient with biochemical recurrence of prostate cancer is essential for appropriate treatment selection. Magnetic resonance imaging (MRI) is the best test for localization and characterization of locally residual or recurrent prostate cancer. It is essential for the radiologist involved in prostate MRI interpretation to be familiar with key imaging findings and advantages of different sequences to reach a confident diagnosis in the post-treatment setting. In this pictorial review, we present imaging findings of post-treatment prostate MRI including expected post-treatment anatomy and imaging characteristics, and the typical appearances of local tumor recurrence after radical prostatectomy, radiation therapy, and focal therapy for prostate cancer. While a multi-parametric MRI approach remains key just as in the treatment-naïve gland, this review emphasizes the much greater importance of the dynamic contrast-enhanced MRI sequence for evaluation in the post-treatment setting.
Literatur
1.
Zurück zum Zitat Panebianco V, Barchetti F, Sciarra A, et al (2013) Prostate cancer recurrence after radical prostatectomy: the role of 3T diffusion imaging in multiparametric magnetic resonance imaging. Eur Radiol 23(6):1745-1752.CrossRef Panebianco V, Barchetti F, Sciarra A, et al (2013) Prostate cancer recurrence after radical prostatectomy: the role of 3T diffusion imaging in multiparametric magnetic resonance imaging. Eur Radiol 23(6):1745-1752.CrossRef
2.
Zurück zum Zitat Wu LM, Xu JR, Gu HY, et al (2012) Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy. Clin Oncol 25(4):252-264.CrossRef Wu LM, Xu JR, Gu HY, et al (2012) Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy. Clin Oncol 25(4):252-264.CrossRef
3.
Zurück zum Zitat Kitajima K, Hartman RP, Froemming AT, et al (2015) Detection of local recurrence of prostate cancer after radical prostatectomy using endorectal coil MRI at 3T: addition of DWI and dynamic contrast enhancement to T2-weighted MRI. AJR Am J Roentgenol 205(4)807-816.CrossRef Kitajima K, Hartman RP, Froemming AT, et al (2015) Detection of local recurrence of prostate cancer after radical prostatectomy using endorectal coil MRI at 3T: addition of DWI and dynamic contrast enhancement to T2-weighted MRI. AJR Am J Roentgenol 205(4)807-816.CrossRef
4.
Zurück zum Zitat Cooperberg MR and Carroll PR (2015) Trends in management for patients with localized prostate cancer, 1990-2013. JAMA 314:80-82.CrossRef Cooperberg MR and Carroll PR (2015) Trends in management for patients with localized prostate cancer, 1990-2013. JAMA 314:80-82.CrossRef
5.
Zurück zum Zitat Walz J, Chun FKH, Klein EA, et al (2009) Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. J Urol 181:601-608.CrossRef Walz J, Chun FKH, Klein EA, et al (2009) Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. J Urol 181:601-608.CrossRef
6.
Zurück zum Zitat Cooperberg MR, Hilton JF, Carroll PR (2011) The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer 117:5039-46.CrossRef Cooperberg MR, Hilton JF, Carroll PR (2011) The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer 117:5039-46.CrossRef
7.
Zurück zum Zitat Khan MA and Partin AW (2004) Management of patients with an increasing prostate-specific antigen after radical prostatectomy. Curr Urol Rep 5(3)179-187.CrossRef Khan MA and Partin AW (2004) Management of patients with an increasing prostate-specific antigen after radical prostatectomy. Curr Urol Rep 5(3)179-187.CrossRef
8.
Zurück zum Zitat Cirillo S, Petracchini M, Scotti L, et al (2009) Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 19(3):761-769. Cirillo S, Petracchini M, Scotti L, et al (2009) Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 19(3):761-769.
9.
Zurück zum Zitat Linder BJ, Kawashima A, Woodrum DA, et al (2014) Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging. Can J Urol 21(3):7283-7289.PubMed Linder BJ, Kawashima A, Woodrum DA, et al (2014) Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging. Can J Urol 21(3):7283-7289.PubMed
10.
Zurück zum Zitat Sharma V, Nehra A, Colicchia M, et al (2018) Multiparametric magnetic resonance imaging is an independent predictor of salvage radiotherapy outcomes after radical prostatectomy. Eur Urol 73:879-887.CrossRef Sharma V, Nehra A, Colicchia M, et al (2018) Multiparametric magnetic resonance imaging is an independent predictor of salvage radiotherapy outcomes after radical prostatectomy. Eur Urol 73:879-887.CrossRef
11.
Zurück zum Zitat Capek S, Howe BM, Amrami KK, and Spinner RJ (2015) Perineural spread of pelvic malignancies to the lumbosacral plexus and beyond: clinical and imaging patterns. Neurosurg Focus 39(3):1-12.CrossRef Capek S, Howe BM, Amrami KK, and Spinner RJ (2015) Perineural spread of pelvic malignancies to the lumbosacral plexus and beyond: clinical and imaging patterns. Neurosurg Focus 39(3):1-12.CrossRef
12.
Zurück zum Zitat Odisho AY, Washington SL 3rd, MEng MV, et al (2013) Benign prostate glandular tissue at radical prostatectomy surgical margins. Urology 82(1):154-159. Odisho AY, Washington SL 3rd, MEng MV, et al (2013) Benign prostate glandular tissue at radical prostatectomy surgical margins. Urology 82(1):154-159.
13.
Zurück zum Zitat Shah R, Bassily N, Wei J, et al (2000) Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors. Urology 56:721-725.CrossRef Shah R, Bassily N, Wei J, et al (2000) Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors. Urology 56:721-725.CrossRef
14.
Zurück zum Zitat Kohl SK, Balaji KC, Smith LM, et al (2007) Clinical significance of benign glands at surgical margins in robotic radical prostatectomy specimens. Urology 69:1112-1116.CrossRef Kohl SK, Balaji KC, Smith LM, et al (2007) Clinical significance of benign glands at surgical margins in robotic radical prostatectomy specimens. Urology 69:1112-1116.CrossRef
15.
Zurück zum Zitat Kernek KM, Koch MO, Daggy JK, et al (2005) The presence of benign prostatic glandular tissue at surgical margins does not predict PSA recurrence. J Clin Pathol 58:725-728.CrossRef Kernek KM, Koch MO, Daggy JK, et al (2005) The presence of benign prostatic glandular tissue at surgical margins does not predict PSA recurrence. J Clin Pathol 58:725-728.CrossRef
16.
Zurück zum Zitat Yoshida K, Takahashi N, Karnes RJ, and Froemming AT (2019) Prostatic remnant after prostatectomy: MR findings and prevalence in clinical practice. AJR Am J Roentgenol epub ahead of print. Yoshida K, Takahashi N, Karnes RJ, and Froemming AT (2019) Prostatic remnant after prostatectomy: MR findings and prevalence in clinical practice. AJR Am J Roentgenol epub ahead of print.
17.
Zurück zum Zitat Roach M 3rd, Hanks G, Thames H Jr, et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65(4):965-974.CrossRef Roach M 3rd, Hanks G, Thames H Jr, et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65(4):965-974.CrossRef
18.
Zurück zum Zitat Roy C, Foudi F, Charton J, et al (2013) Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy. AJR Am J Roentgenol 200(4):W361-368.CrossRef Roy C, Foudi F, Charton J, et al (2013) Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy. AJR Am J Roentgenol 200(4):W361-368.CrossRef
19.
Zurück zum Zitat Sexton SJ, Lavien G, Said N, et al (2019) Magnetic resonance imaging features of pubic symphysis urinary fistula with pubic bone osteomyelitis in the treated prostate cancer patient. Abdom Radiol 44(4):1453-1460.CrossRef Sexton SJ, Lavien G, Said N, et al (2019) Magnetic resonance imaging features of pubic symphysis urinary fistula with pubic bone osteomyelitis in the treated prostate cancer patient. Abdom Radiol 44(4):1453-1460.CrossRef
20.
Zurück zum Zitat Padhani AR, Gapinski CJ, Macvicar DA, et al (2001) Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology 218:365-74.CrossRef Padhani AR, Gapinski CJ, Macvicar DA, et al (2001) Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology 218:365-74.CrossRef
21.
Zurück zum Zitat Hotker AM, Mazaheri Y, Zheng J, et al (2015) Prostate cancer: assessing the effects of androgen-deprivation therapy using quantitative multi-parametric MRI. Eur Radiol 25(9):2665-2672.CrossRef Hotker AM, Mazaheri Y, Zheng J, et al (2015) Prostate cancer: assessing the effects of androgen-deprivation therapy using quantitative multi-parametric MRI. Eur Radiol 25(9):2665-2672.CrossRef
22.
Zurück zum Zitat Chen M, Hricak H, Kalbhen CL, et al (1996) Hormonal ablation of prostate cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. AJR Am J Roentgenol 166:1157-63.CrossRef Chen M, Hricak H, Kalbhen CL, et al (1996) Hormonal ablation of prostate cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. AJR Am J Roentgenol 166:1157-63.CrossRef
23.
Zurück zum Zitat Valerio M, Ahmed HU, Emberton M, et al (2014) The role of focal therapy in the management of localized prostate cancer: a systematic review. Eur Urol 66:732-751.CrossRef Valerio M, Ahmed HU, Emberton M, et al (2014) The role of focal therapy in the management of localized prostate cancer: a systematic review. Eur Urol 66:732-751.CrossRef
24.
Zurück zum Zitat Baydoun A, Traughber B, Morris N, et al (2017) Outcomes and toxicities in patients treated with definitive focal therapy for primary prostate cancer: systematic review. Future Oncol 13:649-663.CrossRef Baydoun A, Traughber B, Morris N, et al (2017) Outcomes and toxicities in patients treated with definitive focal therapy for primary prostate cancer: systematic review. Future Oncol 13:649-663.CrossRef
25.
Zurück zum Zitat Sanda MG, Cadeddu JA, Kirkby E, et al (2018) Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options. J Urol 199(4):990-997. Sanda MG, Cadeddu JA, Kirkby E, et al (2018) Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options. J Urol 199(4):990-997.
26.
Zurück zum Zitat Kitajima K, Murphy RC, Nathan MA, et al (2014) Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. J Nucl Med 55: 223-32.CrossRef Kitajima K, Murphy RC, Nathan MA, et al (2014) Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. J Nucl Med 55: 223-32.CrossRef
27.
Zurück zum Zitat Woo S, Kim SY, Kim SH, and Cho JY (2016) Identification of bone metastasis with routine prostate MRI: a study of patients with newly diagnosed prostate cancer. Am J Roentgenol AJR 206:1156-1163.CrossRef Woo S, Kim SY, Kim SH, and Cho JY (2016) Identification of bone metastasis with routine prostate MRI: a study of patients with newly diagnosed prostate cancer. Am J Roentgenol AJR 206:1156-1163.CrossRef
Metadaten
Titel
Post-treatment prostate MRI
verfasst von
Theodora A. Potretzke
Adam T. Froemming
Rajan T. Gupta
Publikationsdatum
02.12.2019
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 7/2020
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02348-x

Weitere Artikel der Ausgabe 7/2020

Abdominal Radiology 7/2020 Zur Ausgabe

Special Section: Male Pelvis

Imaging of scrotal masses

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.